Looking to Partner with the World CNS Series?
Following a year of significant pharma acquisitions, approvals of transformative drugs the first of their kind, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, 2026 is set to continue this momentum, with more companies prioritizing neuroscience drug development than ever before.
If you have relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your capabilities through a bespoke commercial package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the Sponsorship Prospectus
Join 160+ CNS Oligo Experts
Be part of leading discussions with your peers spanning end-to-end development of siRNAs, ASOs, aptamers and more.
Showcase Your Solutions
Align your brand with leading innovators and gain visibility in a space defined by active engagement and strategic partnerships.
Explore the Brand-New Agenda
Immerse in fresh data drops, breakthrough approaches in CNS delivery, and a program built to spark conversations.